For instance, for tumors routinely identified as immunologically cold [224]—harboring either few or exhausted immune cells—IL-1β is likely to exert additional effects through the activation of signaling pathways in bystander normal cells inhabiting the tumor-associated tissue microenvironment. The gene discussed is IL1B; the disease is neoplasm.